3,122
Views
115
CrossRef citations to date
0
Altmetric
Register studies, hip and knee

Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively

A prospective cohort study of 1,335 patients

, , &
Pages 39-48 | Received 08 Jan 2013, Accepted 24 Sep 2013, Published online: 29 Nov 2013

  • Aletaha D, Funovits J, Ward MM, Smolen JS, Kvien TK. Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline. Arthritis Care Res 2009; (61): 313-20.
  • Augestad LA, Rand-Hendriksen K. Influence of construct-irrelevant factors and effects of methodological choices on EQ-5D health state valuation. 2012. Oslo, Norway, Faculty of Medicine, University of Oslo.
  • Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; (15): 1833-40.
  • Brooks R. EuroQol: the current state of play. Health Policy 1996; (37): 53-72.
  • Browne J, Jamieson L, Lewsey J, van der Meulen J, Black N, Cairns J, Lamping D, Smith S, Copley L, Horrocks J. Patient Reported Outcome Measures (PROMs) in Elective Surgery. Report to the Department of Health 2007; 24-4-0013.
  • Campbell MK, Torgerson DJ. Bootstrapping: estimating confidence intervals for cost-effectiveness ratios. QJM 1999; 92: 177-82.
  • Chard J, Kuczawski M, van der Meulen J. Patient outcomes in surgery. A report comparing independent sector treatment centres and NHS providers. POiS Audit Steering Committee, Clinical Effectiveness Unit, The Royal College of Surgeons of England 2011; 24-4-0013.
  • Cheung Kajang, Oemar Mandy, Oppe Mark, Rabin Rosalin. EQ-5D User Guide. Basic information on how to use EQ-5D. Version 2.0. March 2009. 2009. The EuroQoL Group.
  • Clinical Effectiveness Unit. Questionnaire for patients who have had hip surgery. 2009. POIS Audit, The Royal College of Surgeons of England.
  • Davis AM. The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative. 2008.
  • Davis AM, Perruccio AV, Cañizares M, Hawker GA, Roos EM, Lohmander LS. Comparative Evaluation of Validity and Responsiveness of the HOOS-PS/KOOS-PS and WOMAC Following Total Joint Replacement. 2008a. OARSI, Rome, Italy, September 2008.
  • Davis AM, Perruccio AV, Canizares M, Tennant A, Hawker GA, Conaghan PG, Roos EM, Jordan JM, Maillefert JF, Dougados M, Lohmander LS. The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008b; 16: 551-9.
  • Davis AM, Perruccio AV, Lohmander LS. Minimally clinically important improvement: all non-responders are not really non-responders an illustration from total knee replacement. Osteoarthritis Cartilage 2012; 20: 364-7.
  • Dawson J, Fitzpatrick R, Frost S, Gundle R, Lardy-Smith P, Murray D. Evidence for the validity of a patient-based instrument for assessment of outcome after revision hip replacement. J Bone Joint Surg (Br) 2001; 83: 1125-9.
  • de Vet HC, Ostelo RW, Terwee CB, van der RN, Knol DL, Beckerman H, Boers M, Bouter LM. Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res 2007; 16: 131-42.
  • de Vet HC, Terwee CB, Mokkink L, Knol DL. Interpretability. In: Measurements in medicine- Practical guides to biostatistics and epidemiology. Cambridge: Cambridge University Press, 2011; 227-68.
  • Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care 2002; 40: 442-6.
  • Dougados M, Brault Y, Logeart I, van der Heijde D, Gossec L, Kvien T. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID). Arthritis Res Ther 2012; 14: R129.
  • Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, Cooper R, Felix LM, Pratap S. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev 2009;MR000008.
  • Escobar A, Gonzalez M, Quintana JM, Vrotsou K, Bilbao A, Herrera-Espineira C, Garcia-Perez L, Aizpuru F, Sarasqueta C. Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. Osteoarthritis Cartilage 2012; 20: 87-92.
  • Fawcett T. An introduction to ROC analysis. Pattern Recognition Letters 2006; 27: 861-74.
  • Fiellin DA, Feinstein AR. Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. J Investig Med 1998; 46: 22-6.
  • Froud RJ. ROCMIC: Stata module to estimate minimally important change (MIC) thresholds for continuous clinical outcome measures using ROC curves. 2002. Computer program. http://EconPapers.repec.org/RePEc:boc:bocode:s457052.
  • Hays RD, Farivar SS, Liu H. Approaches and Recommendations for Estimating Minimally Important Differences for Health-Related Quality of Life Measures. COPD 2005; 2: 63-7.
  • Heiberg T, Kvien TK, Mowinckel P, Aletaha D, Smolen JS, Hagen KB. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 967-71.
  • Horan FT. Joint registries. Editorial. J Bone Joint Surg (Br) 2010; 92: 749-50.
  • Jansson KA, Granath F. Health-related quality of life (EQ-5D) before and after orthopedic surgery. Acta Orthop 2010; 82: 82-9.
  • Kamper-Jørgensen F. Danskernes sundhed 2005 Skema 2. 2005. Statens Institut for Folkesundhed, Socialforskningsinstituttet.
  • Keurentjes JC, Van Tol FR, Fiocco M, Schoones JW, Nelissen RG. Minimal clinically important differences in health-related quality of life after total hip or knee replacement. Bone Joint Res 2012; 1: 71-7.
  • King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoeconomics Outcomes Res 2011; 11: 171-84.
  • Kvamme MK, Kristiansen IS, Lie E, Kvien TK. Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. J Rheumatology 2010; 37: 26-31.
  • Kvien TK, Heiberg T, Hagen KB. Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? Ann Rheum Dis (Suppl 3) 2007; 66: iii40-iii41.
  • Linde L. Health-related quality of life in patients with rheumatoid arthritis A comparative validation of selected measurement instruments. 2009. Copenhagen, Denmark, Department of Rheumatology, Hvidovre Hospital, Faculty of Health Sciences, University of Copenhagen.
  • Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Care Res 2007; 57: 133-9.
  • Maksymowych WP, Gooch K, Dougados M, Wong RL, Chen N, Kupper H, van der HD. Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics. Arthritis Care Res (Hoboken) 2010; 62: 826-34.
  • McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoeconomics Outcomes Res 2011; 11: 163-9.
  • Mitchell MN. wtest. 2000. Statistical Computing and Consulting, UCLA, Academic Technology Services.
  • Nilsdotter AK, Lohmander LS, Klassbo M, Roos EM. Hip disability and osteoarthritis outcome score (HOOS)–validity and responsiveness in total hip replacement. BMC Musculoskelet Disord 2003; 4: 10.
  • Paulsen A, Overgaard S, Lauritsen JM. Quality of data entry using single entry, double entry and automated forms processing. An example based on a study of patient-reported outcomes. PLoS ONE 2012a; 7: e35087.
  • Paulsen A, Pedersen AB, Overgaard S, Roos EM. Feasibility of 4 patient-reported outcome measures in a registry setting. Acta Orthop 2012b; 8): 321-7.
  • Quintana JM, Aguirre U, Barrio I, Orive M, Garcia S, Escobar A. Outcomes after total hip replacement based on patients’ baseline status: What results can be expected? Arthritis Care Res 2012; 64: 563-72.
  • Rasch G. Probabilistic model for some intelligence and attainment tests. University of Chicago Press,Chicago 1960.
  • Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-9.
  • Rolfson O. Patient-reported outcome measures and health-economic aspects of total hip arthroplasty. A study of the Swedish Hip Arthroplasty Register. 2010. Institute of Clinical Sciences at Sahlgrenska Academy, University of Gothenburg. 10-12-2010.
  • Rolfson O, Karrholm J, Dahlberg LE, Garellick G. Patient-reported outcomes in the Swedish Hip Arthroplasty Register: Results of a nationwide prospective observational study. J Bone Joint Surg (Br) 2011; 93: 867-75.
  • Roos EM. A User’s Guide to: Hip disability and Osteoarthritis Outcome Score HOOS. Updated May 2008. 2003.
  • Shi HY, Chang JK, Wong CY, Wang JW, Tu YK, Chiu HC, Lee KT. Responsiveness and minimal important differences after revision total hip arthroplasty. BMC Musculoskeletal Disorders 2010; 11: 261.
  • The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
  • Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005; 64: 29-33.
  • Tubach F, Dougados M, Falissard B, Baron G, Logeart I, Ravaud P. Feeling good rather than feeling better matters more to patients. Arthritis Care Res 2006; 55: 526-30.
  • Tubach F, Giraudeau B, Ravaud P. The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates. J Clin Epidemiol 2009; 62: 725-8.
  • Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, Felson DT, Hajjaj-Hassouni N, Hochberg M, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res 2012; 64: 1699-707.
  • Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 1523-32.
  • Wilcox RR, in VL, Thompson KL. New monte carlo results on the robustness of the anova f, w and f statistics. Communications in Statistics - Simulation and Computation 1986; 15: 933-43.
  • Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health 2009; 37: 459-66.
  • Wylde V, Blom AW. The failure of survivorship. Editorial. J Bone Joint Surg (Br) 2011; 93: 569-70.